Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.
Applying lessons of raw materials’ characterization and supply-chain control from the semiconductor industry allow more rigorous control of the biopharmaceutical manufacturing process.
The pressure to improve operational technology performance combined with the rapid pace of technology change is driving adoption of new automation models in pharmaceutical manufacturing.
The pressure to improve operational technology performance combined with the rapid pace of technology change is driving adoption of new automation models in pharmaceutical manufacturing.
Despite preparative work by the bio/pharma industry, any Brexit scenario will result in regulatory implications and increased costs.
In batch production, efficient exception management means reducing the time required to identify, review, and resolve process exceptions. Incorporating review by exception functionality within manufacturing execution system (MES) software can streamline biopharmaceutical product release.
In this seminar, we will talk about two different models that can be used for various in-vitro tests. On demand presentation Register free
Using a specific addition method to wet the powder bed in twin-screw granulation using a foam binder improves robustness for continuous solid-dosage drug product manufacturing.
The authors review developments in wet granulation using a twin-screw extruder.
How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.
Visualization using virtual and mixed reality can aid with biopharma manufacturing facility design and training.
Tracking and implementing label changes are crucial to the lifecycle of a marketed drug product.
Taiwan Pharmaceutical Alliance provide license in/out, CMO/CDMO, and beyond, for API & FDF. Taiwan is a PIC/S & ICH member. TPA products are launched in the US, EU, Japan.
AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.
Two contract services providers in Scotland combine innovative business leadership with biotechnology research and development.
The past year has seen significant consolidation of mid-size CROs, with many of them being bought or put up for sale. In particular, the top six or seven CROs seem to be signing more preferred partner deals, such as Pfizer teaming with Parexel and ICON, and Takeda?s deals with Covance and Quintiles, which is driving mid-size CROs growth through major acquisitions.
Advanced dynamic process control of a fluid-bed granulation process using PAT data improves product quality.
Advanced dynamic process control of a fluid-bed granulation process using PAT data improves product quality.
Pharma bottles are an integrated part of the final medicine. That’s why Stoelzle cares that much about quality and reliability when manufacturing safe packaging for healthy products in soda lime Type III quality.
Advanced dynamic process control of a fluid-bed granulation process using PAT data improves product quality.
Advanced dynamic process control of a fluid-bed granulation process using PAT data improves product quality.
The purpose of this research was to formulate modified liquisolid compacts (MLSC) of RLX for improved dissolution in immediate-release tablet formulations.
Regulators have exaggerated expectations for simulated media fills.
SCHOTT has run a series of line tests to prove the efficacy and efficiency of its modular EVERIC product concepts against vial breakage. The results show a great increase in glass strength. | Sponsored Content
LabSolutions Insight Biologics, a complete workflow from data acquisition to analysis and reporting! Your dedicated workspace for oligonucleotide characterisation.
Synthetic biology can help researchers circumvent the challenges of traditional methods of antibody generation.